MARKERS OF CLINICAL COMPLEXITY IN HOSPITALISED OLDER PATIENTS WITH PARKINSON'S DISEASE AND ASSOCIATIONS WITH OUTCOMES

被引：0
|
作者：
Torsney, K. M.
Romero-Ortuno, R.
机构：
[1] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Med Elderly, Cambridge, England
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol Unit, Cambridge, England
来源：
AGE AND AGEING | 2019年 / 48卷
关键词：
D O I：
10.1093/ageing/afy211.49
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
49
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Genetic complexity and Parkinson's disease
    Gasser, T
    MullerMyhsok, B
    Wszolek, ZK
    Durr, A
    Vaughan, JR
    Bonifati, V
    Meco, G
    Bereznai, B
    Oehlmann, R
    Agid, Y
    Brice, A
    Wood, N
    SCIENCE, 1997, 277 (5324) : 388 - 389
  • [42] Associations between clinical and performance measures with self-restricted driving practices in older adults with Parkinson's disease
    Crizzle, A. M.
    Myers, A. M.
    Almeida, Q. J.
    Roy, E.
    MOVEMENT DISORDERS, 2013, 28 : S380 - S381
  • [43] Association of CSF T and β-amyloid markers with neuropsychological, morphometric and clinical outcomes in Parkinson's disease: A longitudinal study
    Compta, Y.
    Ibarretxe-Bilbao, N.
    Junque, C.
    Camara, A.
    Pont, C.
    Buongiorno, M.
    Valldeoriola, F.
    Tolosa, E.
    Munoz, E.
    Bargallo, N.
    Rios, J.
    Marti, M. J.
    MOVEMENT DISORDERS, 2011, 26 : S149 - S149
  • [44] Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers
    Chahine, Lama M.
    Stern, Matthew B.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 299 - 306
  • [45] Perceptual Features as Markers of Parkinson's Disease: The Issue of Clinical Interpretability
    Mekyska, Jiri
    Smekal, Zdenek
    Galaz, Zoltan
    Mzourek, Zdenek
    Rektorova, Irena
    Faundez-Zanuy, Marcos
    Lopez-de-Ipina, Karmele
    RECENT ADVANCES IN NONLINEAR SPEECH PROCESSING, 2016, 48 : 83 - 91
  • [46] Apathy in Parkinson's disease: serum biochemical markers and clinical features
    Li, L. T.
    Qu, Y.
    Gao, H. L.
    Xiong, Y. J.
    Min, Z.
    Mao, Z. J.
    Li, J. Y.
    Qin, Q. X.
    Wang, D. L.
    Zhao, J. W.
    Xue, Z.
    MOVEMENT DISORDERS, 2022, 37 : S370 - S370
  • [47] Combining clinical and biofluid markers for early Parkinson's disease detection
    Yu, Zhenwei
    Stewart, Tessandra
    Aasly, Jan
    Shi, Min
    Zhang, Jing
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (01): : 109 - 114
  • [48] Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson's disease (PD)
    Julio, K.
    Vakhtin, A.
    Lin, H.
    Birg, A.
    Hoffman, N.
    Nitschke, S.
    Shaff, N.
    Erhardt, E.
    Mayer, A.
    Sugar, D.
    Cedeno, G. Suarez
    Deligtisch, A.
    Richardson, S. Pirio
    Ryman, S.
    MOVEMENT DISORDERS, 2024, 39 : S173 - S173
  • [49] DBS electrode location and clinical outcomes in Parkinson's disease
    Sitek, A.
    Abbas, J.
    Lieberman, D.
    Mahant, P.
    Samanta, J.
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2007, 85 (01) : 56 - 56
  • [50] Associations of fatigue in Parkinson's disease
    Steiger, MJ
    Davies, R
    Brooks, J
    Tyne, H
    Baker, GA
    MOVEMENT DISORDERS, 2002, 17 : S139 - S139
12345